Engineering approaches to immunotherapy. (Q38036894)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22914624%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Engineering approaches to immunotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22914624%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22914624%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Melody A Swartz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22914624%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Sachiko Hirosue

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22914624%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

language of work or name

English

0 references

publication date

1 August 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22914624%20AND%20SRC:MED&resulttype=core&format=json

Science Translational Medicine

11 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22914624%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22914624%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

148

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22914624%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

148rv9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22914624%20AND%20SRC:MED&resulttype=core&format=json

Self-assembly and steric stabilization at heterogeneous, biological surfaces using adsorbing block copolymers

11 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Systems analysis of adaptive immunity by utilization of high-throughput technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Bypassing glycosylation: engineering aglycosylated full-length IgG antibodies for human therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Multivalent antibodies: when design surpasses evolution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Modulation of antibody effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Materials engineering for immunomodulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Nanoparticles target distinct dendritic cell populations according to their size

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

PPS nanoparticles as versatile delivery system to induce systemic and broad mucosal immunity after intranasal administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Immunological mechanisms of vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Intracellular delivery of a protein antigen with an endosomal-releasing polymer enhances CD8 T-cell production and prophylactic vaccine efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

PEG-SS-PPS: reduction-sensitive disulfide block copolymer vesicles for intracellular drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Programming the magnitude and persistence of antibody responses with innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Synthetic mast-cell granules as adjuvants to promote and polarize immunity in lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

A self-assembling peptide acting as an immune adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Modulating adaptive immune responses to peptide self-assemblies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Myeloid-derived suppressor cells as regulators of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Inhibition of tumor-induced myeloid-derived suppressor cell function by a nanoparticulated adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Therapeutic siRNA silencing in inflammatory monocytes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Biomaterial-Based Vaccine Induces Regression of Established Intracranial Glioma in Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

In situ regulation of DC subsets and T cells mediates tumor regression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Promoting tolerance to proteolipid protein-induced experimental autoimmune encephalomyelitis through targeting dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Dendritic cell-targeted pancreatic beta-cell antigen leads to conversion of self-reactive CD4(+) T cells into regulatory T cells and promotes immunotolerance in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Dendritic cell control of tolerogenic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Mechanisms maintaining peripheral tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Reversal of autoimmunity by boosting memory-like autoregulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Immune tolerance after delivery of dying cells to dendritic cells in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Prevention of autoimmune myocarditis through the induction of antigen-specific peripheral immune tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Lymphoid tissue engineering: invoking lymphoid tissue neogenesis in immunotherapy and models of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

The development of LTi cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

New insights into the development of lymphoid tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Secondary lymphoid organs: responding to genetic and environmental cues in ontogeny and the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Tissue-engineered spleen protects against overwhelming pneumococcal sepsis in a rodent model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Generation of a synthetic lymphoid tissue-like organoid in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

CCR7 and its ligands: balancing immunity and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Lymph node stroma broaden the peripheral tolerance paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

The tumor-draining lymph node as an immune-privileged site

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Long-term immunologically competent human peripheral lymphoid tissue cultures in a 3D bioreactor

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Human skin cells support thymus-independent T cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

In vitro stimulation of human influenza-specific CD8+ T cells by dendritic cells pulsed with an influenza virus-like particle (VLP) vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Inverse opal hydrogel-collagen composite scaffolds as a supportive microenvironment for immune cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Fluid flow regulates stromal cell organization and CCL21 expression in a tissue-engineered lymph node microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Enhancing cell therapies from the outside in: Cell surface engineering using synthetic nanomaterials

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Immunotherapy for ovarian cancer: what's next?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

The promise and potential pitfalls of chimeric antigen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Fifteen years of gene therapy based on chimeric antigen receptors: "are we nearly there yet?".

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell-engaging CD19/CD3-bispecific BiTE antibody blinatumomab

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Therapeutic cell engineering with surface-conjugated synthetic nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Arming tumor-reactive T cells with costimulator B7-1 enhances therapeutic efficacy of the T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Generation of GPI-linked CCL5 based chemokine receptor antagonists for the suppression of acute vascular damage during allograft transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Imaging sialylated tumor cell glycans in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Copper-free click chemistry in living animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Immunogenomics and systems biology of vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Evolving concepts of specificity in immune reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Systems biology in immunology: a computational modeling perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Computational modeling of cellular signaling processes embedded into dynamic spatial contexts

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Enhancing protease activity assay in droplet-based microfluidics using a biomolecule concentrator

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

A high-throughput single-cell analysis of human CD8⁺ T cell functions reveals discordance for cytokine secretion and cytolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Multimodal imaging of nanovaccine carriers targeted to human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Noninvasive detection of therapeutic cytolytic T cells with 18F-FHBG PET in a patient with glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Rapid, efficient functional characterization and recovery of HIV-specific human CD8+ T cells using microengraving

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

A model for personalized in vivo analysis of human immune responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Monoclonal antibodies isolated without screening by analyzing the variable-gene repertoire of plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

Signaling thresholds govern heterogeneity in IL‐7‐receptor‐mediated responses of naïve CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

New designs for cancer vaccine and artificial veto cells: an emerging palette of protein paints

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003763

10.1126/SCITRANSLMED.3003763

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22914624%20AND%20SRC:MED&resulttype=core&format=json

release_pia3lgvkx5gpjepxodtmxckpxq

11 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pia3lgvkx5gpjepxodtmxckpxq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22914624%20AND%20SRC:MED&resulttype=core&format=json